Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


Articles published in J Neurochem

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    March 2024
  1. KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al
    Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human alpha-synuclein A53T transgenic mice during early adulthood.
    J Neurochem. 2024;168:269-287.
    PubMed     Abstract available


    January 2024
  2. CARMONA A, Carboni E, Gomes LC, Roudeau S, et al
    Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
    J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040.
    PubMed     Abstract available


    December 2023
  3. ZHANG F, Yang D, Li J, Du C, et al
    Synaptotagmin-11 regulates immune functions of microglia in vivo.
    J Neurochem. 2023;167:680-695.
    PubMed     Abstract available


  4. RENTSCH P, Egan T, Kuriakose A, Stayte S, et al
    The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias.
    J Neurochem. 2023;167:633-647.
    PubMed     Abstract available


    November 2023
  5. BILLINGS JL, Hilton JBW, Liddell JR, Hare DJ, et al
    Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.
    J Neurochem. 2023;167:337-346.
    PubMed     Abstract available


  6. SONG DY, Yuan L, Cui N, Feng C, et al
    alpha-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
    J Neurochem. 2023;167:461-484.
    PubMed     Abstract available


    September 2023
  7. WANG J, Joseph S, Vingill S, Dere E, et al
    Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain neurons in mice leads to abnormal motor behavior and synaptic defects.
    J Neurochem. 2023 Sep 27. doi: 10.1111/jnc.15962.
    PubMed     Abstract available


  8. MUHAMMAD B, Li H, Gu Y, Xue S, et al
    IL-1beta/IL-1R1 signaling is involved in the propagation of alpha-synuclein pathology of the gastrointestinal tract to the brain.
    J Neurochem. 2023;166:830-846.
    PubMed     Abstract available


  9. CHENG JY, Deng YT, Yu JT
    The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    J Neurochem. 2023;166:972-981.
    PubMed     Abstract available


    July 2023
  10. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
    Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
    J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
    PubMed     Abstract available


    June 2023
  11. GASPAROTTO J, Somensi N, Girardi CS, Bittencourt RR, et al
    Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    J Neurochem. 2023 Jun 28. doi: 10.1111/jnc.15890.
    PubMed     Abstract available


  12. HE H, Zhang Q, Liao J, Lei J, et al
    METTL14 is decreased and regulates m(6) A modification of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2023 Jun 13. doi: 10.1111/jnc.15882.
    PubMed     Abstract available


  13. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    PubMed     Abstract available


    April 2023
  14. MASUKAWA D, Kitamura S, Tajika R, Uchimura H, et al
    Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum.
    J Neurochem. 2023;165:177-195.
    PubMed     Abstract available


  15. BRONTESI L, Imberdis T, Ramalingam N, Dettmer U, et al
    The effects of KTKEGV repeat motif and intervening ATVA sequence on alpha-synuclein solubility and assembly.
    J Neurochem. 2023;165:246-258.
    PubMed     Abstract available


    February 2023
  16. CHEN YH, Kuo YY, You YQ, Lin YT, et al
    Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease.
    J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15794.
    PubMed     Abstract available


  17. TENG X, Mao S, Wu H, Shao Q, et al
    The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    J Neurochem. 2023 Feb 13. doi: 10.1111/jnc.15780.
    PubMed     Abstract available


    January 2023
  18. DE GUILHEM DE LATAILLADE A, Caillaud M, Oullier T, Naveilhan P, et al
    LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines.
    J Neurochem. 2023;164:193-209.
    PubMed     Abstract available


    November 2022
  19. PALDOR I, Madrer N, Vaknine Treidel S, Shulman D, et al
    Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex and Parkinson's disease-related changes.
    J Neurochem. 2022 Nov 10. doi: 10.1111/jnc.15723.
    PubMed     Abstract available


    October 2022
  20. SANTORO M, Fadda P, Klephan KJ, Hull C, et al
    Neurochemical, histological and behavioral profiling of the acute, sub-acute and chronic MPTP mouse model of Parkinson's disease.
    J Neurochem. 2022 Oct 3. doi: 10.1111/jnc.15699.
    PubMed     Abstract available


    September 2022
  21. VAZ M, Martins TS, Henriques AG
    Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: methodologies applied from cells to biofluids.
    J Neurochem. 2022 Sep 26. doi: 10.1111/jnc.15697.
    PubMed     Abstract available


    April 2022
  22. SKITEVA O, Yao N, Sitzia G, Chergui K, et al
    LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.
    J Neurochem. 2022;161:158-172.
    PubMed     Abstract available


    March 2022
  23. REN J, Pan C, Wang Y, Xue C, et al
    Plasma alpha-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's Disease.
    J Neurochem. 2022 Mar 2. doi: 10.1111/jnc.15601.
    PubMed     Abstract available


  24. XUE J, Li G, Ji X, Liu ZH, et al
    Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria.
    J Neurochem. 2022;160:540-555.
    PubMed     Abstract available


    February 2022
  25. LO PS, Rymar VV, Kennedy TE, Sadikot AF, et al
    The Netrin-1 Receptor DCC Promotes the Survival of a Subpopulation of Midbrain Dopaminergic Neurons: Relevance for Ageing and Parkinson's Disease.
    J Neurochem. 2022 Feb 4. doi: 10.1111/jnc.15579.
    PubMed     Abstract available


    December 2021
  26. NICASTRO N, Nencha U, Burkhard PR, Garibotto V, et al
    Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
    J Neurochem. 2021 Dec 22. doi: 10.1111/jnc.15561.
    PubMed     Abstract available


    November 2021
  27. GUO YJ, Ayton S, Lei P
    Iron reduces the propagation of pathological alpha-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates alpha-synuclein spreading after injection of preformed fibrils" on page 554.
    J Neurochem. 2021;159:414-416.
    PubMed     Abstract available


    October 2021
  28. LEE CY, Menozzi E, Chau KY, Schapira AHV, et al
    Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    J Neurochem. 2021 Oct 7. doi: 10.1111/jnc.15524.
    PubMed     Abstract available


    September 2021
  29. BIDESI N, Andersen IV, Windhorst AD, Shalgunov V, et al
    The Role of Neuroimaging in Parkinson's Disease.
    J Neurochem. 2021 Sep 17. doi: 10.1111/jnc.15516.
    PubMed     Abstract available


    July 2021
  30. GOLDSTEIN DS, Sullivan P, Holmes C, Lamotte G, et al
    Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
    J Neurochem. 2021;158:554-568.
    PubMed     Abstract available


    June 2021
  31. MASATO A, Bubacco L, Greggio E
    Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metaboli
    J Neurochem. 2021 Jun 28. doi: 10.1111/jnc.15442.
    PubMed     Abstract available


  32. KHAIRNAR A, Ruda-Kucerova J, Arab A, Hadjistyllis C, et al
    Diffusion kurtosis imaging detects the time-dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease.
    J Neurochem. 2021 Jun 9. doi: 10.1111/jnc.15449.
    PubMed     Abstract available


    May 2021
  33. LASHUEL HA
    Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model: This is the reply to a comment "Alpha-synuclein oligomerization and aggregation: A model will always be a model" on the original article "Monit
    J Neurochem. 2021;157:891-898.
    PubMed     Abstract available


    April 2021
  34. PISCHEDDA F, Piccoli G
    LRRK2 at the pre-synaptic site: A 16-years perspective.
    J Neurochem. 2021;157:297-311.
    PubMed     Abstract available


    January 2021
  35. LV Q, Zhong Z, Hu B, Yan S, et al
    MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson's disease.
    J Neurochem. 2021 Jan 15. doi: 10.1111/jnc.15299.
    PubMed     Abstract available


    December 2020
  36. PINNELL JR, Cui M, Tieu K
    Exosomes in Parkinson Disease.
    J Neurochem. 2020 Dec 29. doi: 10.1111/jnc.15288.
    PubMed     Abstract available


  37. ZARATE SM, Pandey G, Chilukuri S, Garcia JA, et al
    Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-beta-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.
    J Neurochem. 2020 Dec 23. doi: 10.1111/jnc.15282.
    PubMed     Abstract available


  38. HADI F, Akrami H, Totonchi M, Farhadi A, et al
    alpha-Synuclein Abnormalities Trigger Focal Tau Pathology, Spreading to Various Brain Areas in Parkinson's Disease.
    J Neurochem. 2020 Dec 2. doi: 10.1111/jnc.15257.
    PubMed     Abstract available


    September 2020
  39. TUO QZ, Lei P
    Iron promotes the clearance of alpha-synuclein: An Editorial for 'H63D variant of the homeostatic iron regulator (HFE) gene alters alpha-synuclein expression, aggregation, and toxicity" on page 177.
    J Neurochem. 2020;155:117-119.
    PubMed     Abstract available


    August 2020
  40. TRINH D, Israwi AR, Arathoon LR, Gleave JA, et al
    The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
    J Neurochem. 2020 Aug 16. doi: 10.1111/jnc.15154.
    PubMed     Abstract available


    July 2020
  41. TOFFOLI M, Smith L, Schapira AHV
    The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriers.
    J Neurochem. 2020;154:11-24.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.